SIETES :: 93212 citas

Resultados de la búsqueda por TRANSVERSAL REFINAR BÚSQUEDA

1.

Aby ES, Rodin H, Debes JD. Proton pump inhibitors and mortality in individuals with COVID-19. The American Journal of Gastroenterology 2020;115:octubre. [Ref.ID 103830]

2.

Almario CV, Chey WD, Spiegel BMR. Increased risk of COVID-19 among users of proton-pump inhibitors. The American Journal of Gastroenterology 2020;115:octubre. [Ref.ID 103795]

3.

Moynihan R, Albarqouni L, Nangla C, Dunn AG, Lexchin J, Bero L. Financial ties between leaders of influential US professional medical associations and industry: cross sectional study. BMJ 2020;369:27 de mayo. [Ref.ID 103650]

4.

Willems RPJ, van Dijk K, Ket JCF, Vandenbroucke-Grauls CMJE. Evaluation of the association between gastric acid suppression and risk of intestinal colonization with multidrug-resistant microorganisms. A systematic review and meta-analysis. JAMA Intern Med 2020;180:1 de abril. [Ref.ID 103547]

5.

Just KS, Dormann H, Böhme M, Schurig M, Schneider KL, Steffens M, Dunow S, Plank-Kiegele B, Ettrich K, Seufferlein T, Gräff I, Igel S, Schricker S, Jaeger SU, Schwab MStingl J. Personalising drug safety—results from the multi-centre prospective observational study on Adverse Drug Reactions in Emergency Departments (ADRED). Eur J Clin Pharmacol 2020;76:marzo. [Ref.ID 103531]

6.

McEvoy JB, Daya N, Rahman F, Hoogeveen RC, Blumenthal RS, Shah AM, Ballantyne CM, Coresh J, Selvin E. Association of isolated diastolic hypertension as defined by the 2017 ACC/AHA blood pressure guideline with incident cardiovascular outcomes. JAMA 2020;323:28 de enero. [Ref.ID 103512]

7.

Kennedy MB, Williams SE, Haq I, Okorie M. UK medical students’ perspectives on practical prescribing teaching and learning provisions: a cross-sectional survey. Eur J Clin Pharmacol 2019;75:octubre. [Ref.ID 103187]

8.

Imperiale TF, Gruber RN, Stump TE, Emmett TW, Monahan PO. Performance characteristics of fecal immunochemical tests for colorectal cancer and advanced adenomatous polyps: a systematic review and meta-analysis. Ann Intern Med 2019:26 de febrero. [Ref.ID 103034]

9.

Valles-Colomer M, Falongy G, Darzi Y, Tigchelaar EF, Wang J, Tito RY, Schiweck C, Kurilshikov A, Joossens M, Wijmenga C, Claes S, Van Oudenhove L, Zhernakova A, Vieira-Silva S, Raes J. The neuroactive potential of the human gut microbiota in quality of life and depression. Nat Microbiol 2019:4 de febrero. [Ref.ID 103027]

10.

Hadland SE, Rivera-Aguirre A, Marshall BDL, Cerdá M. Association of pharmaceutical industry marketing of opioid products with mortality from opioid-related overdoses. JAMA Network Open 2019;2:18 de enero. [Ref.ID 103009]

11.

Vedal TSJ, Steen NE, Birkeland KI, Dieset I, Reponen EJ, Laskemoen JF, Rodevand L, Melle I, Andreassen OA, Molden E, Jönsson EG. Free thyroxine and thyroid-stimulating hormone in severe mental disorders: A naturalistic study with focus on antipsychotic medication. J Psychiatr Res 2018:25 de septiembre. [Ref.ID 102832]

12.

Wen H, Hockenberry JM. Association of medical and adult-use marijuana laws with opioid prescribing for Medicaid enrollees. JAMA Intern Med 2018;178:mayo. [Ref.ID 102740]

13.

O'Connell J, Burke E, O'Dwyer C, Donegan C, McCallion P, McCarron M, Henman MC, O'Dwyer M. Drug burden index to define the burden of medicines in older adults with intellectual disabilities: An observational cross-sectional study. Br J Clin Pharmacol 2018;84:marzo. [Ref.ID 102650]

14.

Öngür D. Dopamine dysfunction in schizophrenia and bipolar disorder - Never the twain shall meet?. JAMA Psychiatry 2017:11 de octubre. [Ref.ID 102090]

15.

Jauhar S, Nour MM, Veronese M, Rogdaki M, Bonoldi I, Azis M, Turkheimer F, McGuire P, Young AH, Howes OD. A tests of the transdiagnostic dopamine hypothesis of psychosis using positron emission tomographic imaging in bipolar affective disorder and schizophrenia. JAMA Psychiatry 2017:11 de octubre. [Ref.ID 102089]

16.

Xu J, Emenanjo O, Ortwerth M, Lurie P. Association of appearance of conflicts of interest with voting behavior at FDA advisory committee meetings—A cross-sectional study. JAMA Intern Med 2017;177:1038-40. [Ref.ID 101664]

17.

Huizinga P, Kluytmans-van den Bergh M, van Rijen M, Willemsen I, van't Veer N, Kluytmans J. Proton pump inhibitor use is associated with extended-spectrum ß-lactamase-producing enterobacteriaceae rectal carriage at hospital admission: a cross-sectional study. Clin Infect Dis 2017;64:361-3. [Ref.ID 101508]

18.

Anónimo. Understanding observational studies. Drug Ther Bull 2016;54:105-8. [Ref.ID 100726]

19.

Johansen ME, Richardson C. Estimation of potential savings through therapeutic substitution. JAMA Intern Med 2016;176:769-75. [Ref.ID 100398]

20.

Salat D, Llop R, Aguilera C, Danés I, Bosch M, Asensio C, Castañeda F, Esterlich E, Vallano A. Therapeutics enquiries about biological agents as a tool to identify safety aspects and patterns of use. European Journal of Hospital Pharmacy 2016;23:161-5. [Ref.ID 100163]